US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Advantage Corp.

14.46

+0.36002.55%

Post-market: 14.45-0.0100-0.07%16:10 EDT

Volume:1.22M

Turnover:17.56M

Market Cap:2.51B

PE:-19.48

High:14.65

Open:14.19

Low:13.94

Close:14.10

Loading ...

Overview Company News Filings

Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Solid Biosciences to Participate at The Citizens Life Sciences Conference

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Fountain Asset Corp. Reports Financial Growth and Strategic Investments in 2024

First Advantage Releases 2025 Global Trends Report

First Advantage to Release First Quarter 2025 Financial Results and Hold Investor Conference Call on May 8, 2025

First Advantage Cut to Equal-Weight From Overweight by Barclays

Barclays Downgrades First Advantage to Equalweight From Overweight, Adjusts Price Target to $15 From $20

MT Newswires Live

U.S. RESEARCH ROUNDUP- Carnival, JLL, Microsoft

First Advantage : Barclays Cuts to Equal-Weight From Overweight

THOMSON REUTERS

Lexeo Therapeutics Says Potential FA Cardiomyopathy Therapy Improves Cardiac Biomarkers

MT Newswires Live

Solid Biosciences to Participate at Upcoming Investor Conferences

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

First Advantage to Host Inaugural Investor Day on May 28, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Binance's new project KernelDAO's investors include the liquidity provider Web3Port.

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results

FA should have seat on board of football regulator, say experts

Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","market":"US","secType":"STK","nameCN":"First Advantage Corp.","latestPrice":14.46,"timestamp":1746129600000,"preClose":14.1,"halted":0,"volume":1218472,"hourTrading":{"tag":"盘后","latestPrice":14.45,"preClose":14.46,"latestTime":"16:10 EDT","volume":22645,"amount":327445.70362,"timestamp":1746130200436},"delay":0,"floatShares":78574292,"shares":173642659,"eps":-0.742168,"marketStatus":"Post-Mkt","change":0.36,"latestTime":"05-01 16:14:00 EDT","open":14.19,"high":14.645,"low":13.94,"amount":17563200.406168,"amplitude":0.05,"askPrice":22.91,"askSize":14,"bidPrice":9.91,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.742168,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":4,"adr":0,"listingDate":1624420800000,"exchange":"NASDAQ","adjPreClose":14.1,"postHourTrading":{"tag":"盘后","latestPrice":14.45,"preClose":14.46,"latestTime":"16:10 EDT","volume":22645,"amount":327445.70362,"timestamp":1746130200436},"volumeRatio":1.212234,"impliedVol":0.3903,"impliedVolPercentile":0.864},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","floatShares":78574292,"roa":"-1.40%","roe":"-9.96%","lyrEps":-0.742168,"volumeRatio":1.212234,"shares":173642659,"dividePrice":0,"high":14.645,"amplitude":0.05,"preClose":14.1,"low":13.94,"week52Low":12.32,"pbRate":"1.92","psRate":"2.92","week52High":20.79,"institutionHeld":0,"latestPrice":14.46,"committee":0.754386,"eps":-0.742168,"divideRate":0,"volume":1218472,"delay":0,"ttmEps":-0.742168,"open":14.19,"prevYearClose":18.73,"prevWeekClose":14.05,"prevMonthClose":14.1,"prevQuarterClose":14.09,"fiveDayClose":14.28,"twentyDayClose":14.87,"sixtyDayClose":19.1,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532077041","title":"Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077041","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077041?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:16","pubTimestamp":1746105360,"startTime":"0","endTime":"0","summary":"Research highlights AAV manufacturing optimization via Lexeo’s Sf9-baculovirus process. NEW YORK, May 01, 2025  -- Lexeo Therapeutics, Inc. , a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its AAV manufacturing approach will be presented at the28thAnnual Meeting of the American Society of Gene & Cell Therapy taking place May 13-17, 2025 in New Orleans, LA.“The data being presented at ASGCT underscore the strength of our industry-leading capabilities in AAV manufacturing with high yield and high quality,” said José Manuel Otero, Chief Technical Officer of Lexeo Therapeutics. “Scientists at Lexeo have optimized a manufacturing platform that can maintain purity and potency while significantly improving scalability of production and reducing cost. Ultimately this platform will enable Lexeo to deliver more efficiently against key milestones in our clinical-stage gene therapy programs an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexeo-therapeutics-present-cmc-data-131600872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0882574139.USD","LU1363072403.SGD","IE00BHPRN162.USD","IE00B1BXHZ80.USD","LU0170899867.USD","IE00BZ1G4Q59.USD","BK4130","BK4006","LU0149725797.USD","FA","AFG","BK4139","BK4539","LU0971096721.USD","LXEO","BK4107","BK4535","CMC","IE00BKVL7J92.USD","BK4117","LU0267386448.USD"],"gpt_icon":0},{"id":"2531226039","title":"Solid Biosciences to Participate at The Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531226039","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531226039?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014400,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., April 30, 2025  -- Solid Biosciences Inc.  , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, President and CEO, will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, May 7, at 12:30 pm ET.About Solid BiosciencesSolid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy , Friedreich’s ataxia , catecholaminergic polymorphic ventricular tachycardia , TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. The Company is also focused on developing innovative libraries of genetic regulators and other enabling technologies with promising potential to significantly impact gene therapy delivery cross-industry. Solid is advancing its diverse pipel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-participate-citizens-life-120000061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLDB","FA","BK4130","BK4535","BK4139","BK4539"],"gpt_icon":0},{"id":"2531808977","title":"EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531808977","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531808977?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"Final 3-year outcome of Focal Ablation versus Radical Prostatectomy  Randomized Controlled Trial  presented at 120th AUA Annual Meeting on Sunday, April 27, 2025.Study achieved its primary endpoint and demonstrated that the rate of treatment failure in the Focal Ablation  group is non-inferior to that in the Radical Prostatectomy  group at the final 36-month follow-up.“The positive results from the FARP randomized controlled trial further validate the role of robotic focal ablation with ultrasound energy in the management of prostate cancer,” said Ryan Rhodes, Chief Executive Officer of EDAP TMS. “Focal One Robotic HIFU was used for the vast majority of the patients treated with focal ablation in this study. This demonstrates Focal One’s leadership position in the rapidly growing treatment category of f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/edap-announces-positive-results-farp-110000974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4117","LU0054578231.USD","EDAP","ITT","FA","LU0053671581.USD","BK4082","RCT","BK4535","BK4161","BK4539","BK4130","BK4107"],"gpt_icon":0},{"id":"2531629229","title":"Fountain Asset Corp. Reports Financial Growth and Strategic Investments in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2531629229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531629229?lang=en_us&edition=fundamental","pubTime":"2025-04-29 08:33","pubTimestamp":1745886815,"startTime":"0","endTime":"0","summary":"Fountain Asset ( ($TSE:FA) ) has shared an update. Fountain Asset Corp. reported its financial results for Q4 and Fiscal 2024, highlighting a 12.5%...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fountain-asset-corp-reports-financial-growth-and-strategic-investments-in-2024?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fountain-asset-corp-reports-financial-growth-and-strategic-investments-in-2024?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FA","BK4539","BK4535","BK4130"],"gpt_icon":0},{"id":"2529376923","title":"First Advantage Releases 2025 Global Trends Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2529376923","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529376923?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:30","pubTimestamp":1745317800,"startTime":"0","endTime":"0","summary":"Findings Point to Rising Demand for Speed, Automation, and Digital Identity Solutions in Background Screening. ATLANTA, April 22, 2025  -- First Advantage Corporation , a leading provider of global software and data in the HR technology industry, today released its 2025 Global Trends Report. Meticulously crafted from hundreds of customer survey responses, and analysis of hundreds of millions of anonymized data points, the latest edition of the proprietary research offers a global perspective and unparalleled insight into the evolving landscape of background screening.As one of the largest background screening providers, First Advantage leverages deep industry expertise and data sources to identify key trends, best practices, and emerging challenges that shape screening programs for 80,000 organizations across more than 200 countries and territories. The report reflects customer insights from a diverse range of verticals, including healthcare, retail and hospitality, transportation, edu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-releases-2025-global-103000709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4130","FA","BK4535"],"gpt_icon":0},{"id":"2528379036","title":"First Advantage to Release First Quarter 2025 Financial Results and Hold Investor Conference Call on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528379036","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528379036?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887600,"startTime":"0","endTime":"0","summary":"ATLANTA, April 17, 2025  -- First Advantage Corporation , a leading provider of global software and data in the HR technology industry, will issue its first quarter 2025 financial results on Thursday, May 8, 2025 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.First Advantage  is a leading provider of global software and data in the HR technology industry. Enabled by its proprietary technology and AI, First Advantage’s platforms, data, and APIs power comprehensive employment background screening, digital identity solutions, and verification services. With a strong emphasis on innovation, automation, and customer success, First Advantage empowers 80,000 organizations to hire smarter and onboard faster. Headquartered in Atlanta, Georgia, First Advantage serves customers in over 200 countries and territories, modernizing hiring and onboarding on a global scale. For more information, please visit our website at https://fadv.com/.Stephanie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-release-first-quarter-110000633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4130","BK4539","FA","BK4535"],"gpt_icon":0},{"id":"2526634505","title":"First Advantage Cut to Equal-Weight From Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2526634505","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526634505?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:05","pubTimestamp":1744286700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2025 08:05 ET (12:05 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA"],"gpt_icon":0},{"id":"2526500515","title":"Barclays Downgrades First Advantage to Equalweight From Overweight, Adjusts Price Target to $15 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2526500515","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526500515?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:47","pubTimestamp":1744285670,"startTime":"0","endTime":"0","summary":"First Advantage (FA) has an average rating of overweight and mean price target of $16.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FA"],"gpt_icon":0},{"id":"2526589044","title":"U.S. RESEARCH ROUNDUP- Carnival, JLL, Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2526589044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526589044?lang=en_us&edition=fundamental","pubTime":"2025-04-10 15:42","pubTimestamp":1744270927,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Carnival, JLL, MicrosoftApril 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carnival, JLL an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nL3N3QO0P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ES","DDOG","NTCT","MSFT","LYFT","INFA","NCLH","FA","RPD","CBRE","EQH","FFIV","SARO","SPIR","BSY","PTC","CCL","JAMF","JLL","NABL","RCL","OVV","TVTX","GEV","RPM","CVLT","WAB","GEN","WWD","LNC","DT","EVCM","POR","CCL.UK","FTNT","VSTM","QLYS","MAN","VRNS","RHI","HXL","OLO","TXT","CRBG","FRPT","NOW"],"gpt_icon":1},{"id":"2526301361","title":"First Advantage : Barclays Cuts to Equal-Weight  From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2526301361","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526301361?lang=en_us&edition=fundamental","pubTime":"2025-04-10 13:34","pubTimestamp":1744263273,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nAZN3OSPBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4130","BK4535","FA"],"gpt_icon":0},{"id":"2525010099","title":"Lexeo Therapeutics Says Potential FA Cardiomyopathy Therapy Improves Cardiac Biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2525010099","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525010099?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:36","pubTimestamp":1744029406,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics  said Monday that interim data from two clinical trials showed that its gene therapy candidate LX2006 led to \"clinically significant\" improvements in cardiac biomarkers and functional measures across all dose cohorts for Friedreich ataxia, or FA, cardiomyopathy.The company said its phase 1/2 trial and Weill Cornell Medicine's phase 1a study also showed that the experimental treatment was associated with increased frataxin protein expression in all participants with cardiac biopsies.Chief Development Officer Sandi See Tai said the data show LX2006 exceeds the thresholds aligned with the US Food and Drug Administration to support accelerated approval in a registrational study expected to begin in early 2026.The company said it expects to begin enrollment in Q2 for the registrational study with a potential efficacy readout in 2027.Lexeo shares were up more than 14% in Monday's premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4130","BK4535","BK4539","LXEO","BK4139","FA"],"gpt_icon":0},{"id":"2525178090","title":"Solid Biosciences to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2525178090","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525178090?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., April  07, 2025  (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056654/0/en/Solid-Biosciences-to-Participate-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4130","SLDB","BK4139","BK4539","BK4535","FA"],"gpt_icon":0},{"id":"2525610018","title":"Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2525610018","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525610018?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:00","pubTimestamp":1744020000,"startTime":"0","endTime":"0","summary":"Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants acro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056510/0/en/Lexeo-Therapeutics-Announces-Positive-Interim-Phase-1-2-Data-for-LX2006-in-Friedreich-Ataxia-Cardiomyopathy-Supporting-Advancement-to-Registrational-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA","BK4139","BK4130","BK4535","BK4539","LXEO"],"gpt_icon":0},{"id":"2524446738","title":"First Advantage to Host Inaugural Investor Day on May 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446738","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446738?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:29","pubTimestamp":1743625740,"startTime":"0","endTime":"0","summary":"ATLANTA, April  02, 2025  (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, today announced it will host its i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/02/3054719/0/en/First-Advantage-to-Host-Inaugural-Investor-Day-on-May-28-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4218","BK4585","BK4588","BK4181","HST","BK4539","FA","BK4130"],"gpt_icon":0},{"id":"2524345118","title":"Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524345118","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524345118?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:00","pubTimestamp":1743508800,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., April 01, 2025  -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 43,374 restricted stock units  to three newly hired employees.The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the applicable employee’s continued service with the Company through each applicable vesting date.This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-reports-inducement-grants-120000642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","QID","SQQQ","SLDB","NDAQ","LU2210149790.SGD","BK4585","MNQmain","BK4139","IE00BKPKM429.USD","BK4535","TQQQ","BK4588","BK4539","FA","BK4112","LU2095319765.USD","QLD","NVIW.SI","LU2210150020.SGD","PSQ","TSYW.SI","BK4130","USJW.SI","IE00B3QW5Z07.USD","NQmain",".IXIC","USAW.SI","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2524319988","title":"Binance's new project KernelDAO's investors include the liquidity provider Web3Port.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524319988","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524319988?lang=en_us&edition=fundamental","pubTime":"2025-04-01 17:46","pubTimestamp":1743500760,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 1st, according to RootData, in this Binance Megadrop event, the upcoming project to be listed is KernelDAO (KERNEL), with liquidity provider Web3Port as one of the investors.Pre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/287804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4124","BK4539","IE00BZ199S13.USD","LU1815336091.USD","BK4130","VC","BK4535","FA","LU0757428866.USD"],"gpt_icon":0},{"id":"2521746991","title":"Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746991","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746991?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI across participants with abnormal LVMI at baseline, frataxin expression to be evaluated for any increase from baseline rather than numerical threshold. Interim update from cohort 1 of LX2020 HEROIC-PKP2 Phase 1/2 trial: observed 71% and 115% increases in PKP2 protein expression in first two post-treatment biopsies; first participant evaluated 6-months after dosing experienced 67% reduction in premature ventricular contractions . Completed enrollment of cohort 2 of LX2020 HEROIC-PKP2 Phase 1/2 trial; interim clinical data update expected in second half of 2025. LX2020 has been generally well tolerated with no treatment-related serious adverse events to date. Cash, cash equivalents and investments of $128.5 million expected to provide operational runway into 2027. NEW YORK, March 24, 2025  -- Lexeo Therapeutics, Inc. , a clinical stage genetic medi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexeo-therapeutics-reports-fourth-quarter-110000124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LXEO","FA","BK4130","BK4539","BK4139","BK4535"],"gpt_icon":0},{"id":"2521469997","title":"Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521469997","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521469997?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval. FDA recommended measuring skin FXN concentrations to support evidence of effectiveness for accelerated approval pathway and acknowledged submitted data appear sufficient to support relationship between increased skin FXN concentrations and relevant tissues such as heart, dorsal root ganglia and skeletal muscle. Larimar is continuing discussions with FDA on the adequacy of the safety data set to support BLA submission. BLA seeking accelerated approval targeted for submission by year-end 2025. FDA and EMA feedback obtained on global Phase 3 study protocol; study planned to initiate in mid-2025. Dr. Ben-Maimon continued, “Our open label extension  study continues to advance, with some participants on daily treatment for up to one year. We continue to actively enroll study participants, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/larimar-therapeutics-provides-nomlabofusp-development-110000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","LRMR","PK","BK4218","BK4130","BK4139","FA","FXN","LENZ","BK4181","BK4539"],"gpt_icon":0},{"id":"2520411107","title":"FA should have seat on board of football regulator, say experts","url":"https://stock-news.laohu8.com/highlight/detail?id=2520411107","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520411107?lang=en_us&edition=fundamental","pubTime":"2025-03-20 08:01","pubTimestamp":1742428860,"startTime":"0","endTime":"0","summary":"MANCHESTER, ENGLAND – MARCH 02: A detailed view of the FA Cup badge on a Mitre Ultimax Pro Emirates FA Cup 2024/25 match ball prior to the Emirates FA Cup Fifth Round match between Manchester United and Fulham at Old Trafford on March 02, 2025 in Manchester, England.  The Football Association  should have a seat on the board of the independent football regulator, argues a new report by consultants LCP.LCP’s sports analytics and advisory unit calls for the incoming regulator to “work closely with the FA to guide its reform and build a modern football governance structure”.They add: “The focus should be on improving and strengthening the FA, not sidelining it. To support this, the regulator should offer the FA a seat on its board.”The regulator has in part been conceived to deal with matters that the FA and Premier League is seen as having failed to tackle effectively, such as financial redistribution and tests for prospective owners and directors of football clubs.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2202849478.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2202849478.jpg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/fa-should-have-seat-on-board-of-football-regulator-say-experts/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4130","FA","BK4535","BK4539"],"gpt_icon":0},{"id":"2518423852","title":"Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518423852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518423852?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604820,"startTime":"0","endTime":"0","summary":"Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039587/0/en/Design-Therapeutics-Highlights-Progress-Across-Lead-GeneTAC-Programs-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0868494617.USD","LU0820562030.AUD","LU0868494708.USD","PRGS","PD","LU0820561818.USD","SG9999001440.SGD","LU1035775433.USD","BK4585","LU0823411888.USD","LU0942090050.USD","LU0320765646.SGD","BK4535","LU2756315664.SGD","PK","LU1162221912.USD","LU0823434740.USD","BK4588","LU1674673691.USD","BK4539","LU0943347566.SGD","FA","BK4181","IE00B1XK9C88.USD","BK4566","LU1093756168.USD","BK4533","HD","IE00BKVL7J92.USD","BK4534","BK4023","LU1778281490.HKD","LU1929549753.HKD","LU2756315318.SGD","LU1093756325.SGD","BK4218","LU0234572021.USD","IE00BWXC8680.SGD","BK4097","DSGN","LU1169590202.USD","LU0079474960.USD","LU1496350171.SGD","IE00BZ1G4Q59.USD","LU1914381329.SGD","LU1989772840.SGD","BK4504","BK4505","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":135,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FA\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"FA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.09,"defaultRemindTime":1746691200000,"name":null,"time":"Pre-Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"FA","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2024-11-12","symbol":"FA","fiscalQuarterEnding":"2024/09","expectedEps":0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":0.21},{"market":"US","date":"2024-08-08","symbol":"FA","fiscalQuarterEnding":"2024/06","expectedEps":0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":0.18},{"market":"US","date":"2024-05-09","symbol":"FA","fiscalQuarterEnding":"2024/03","expectedEps":0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FA\",market:\"US\",,,undefined,":[{"executeDate":"2023-08-18","recordDate":"2023-08-21","paymentDate":"2023-08-31","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.3,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3,"analysts":10,"updateTime":1744344000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FA","date":"2025-04-30","current":-22.549154,"percent":0.2116,"low":-676.959328,"twenty":-63.012035,"median":39.646099,"eighty":73.582885,"high":704.194102,"avg":26.258533,"sd":252.018889,"marketCap":2486562876},"quantilePoints":[{"date":"2021-06-25","current":-69.598825,"twenty":-67.156035,"median":-65.514401,"eighty":-0.000033,"marketCap":3136610250},{"date":"2021-07-02","current":-67.835112,"twenty":-69.001876,"median":-67.665525,"eighty":-52.411527,"marketCap":3057125000},{"date":"2021-07-09","current":-67.529854,"twenty":-68.242123,"median":-67.037596,"eighty":-65.060656,"marketCap":3043367937},{"date":"2021-07-16","current":-63.731088,"twenty":-67.814762,"median":-65.766141,"eighty":-64.857151,"marketCap":2872168937},{"date":"2021-07-23","current":-64.273769,"twenty":-67.740143,"median":-65.749183,"eighty":-64.558676,"marketCap":2896625937},{"date":"2021-07-30","current":-66.512327,"twenty":-67.597689,"median":-65.514401,"eighty":-64.294119,"marketCap":2997511062},{"date":"2021-08-06","current":-62.442221,"twenty":-67.529854,"median":-65.138666,"eighty":-63.751438,"marketCap":2814083562},{"date":"2021-08-13","current":-146.718947,"twenty":-67.597689,"median":-65.189543,"eighty":-63.731088,"marketCap":3657850062},{"date":"2021-08-20","current":-146.780259,"twenty":-69.151113,"median":-65.623312,"eighty":-63.751438,"marketCap":3659378625},{"date":"2021-08-27","current":-143.775984,"twenty":-140.869809,"median":-66.512327,"eighty":-64.070263,"marketCap":3584479062},{"date":"2021-09-03","current":-142.856308,"twenty":-141.458401,"median":-66.664957,"eighty":-64.273769,"marketCap":3561550625},{"date":"2021-09-10","current":-147.945181,"twenty":-142.488438,"median":-67.343308,"eighty":-64.287336,"marketCap":3688421312},{"date":"2021-09-17","current":-136.418578,"twenty":-142.807259,"median":-67.699442,"eighty":-64.375521,"marketCap":3401051562},{"date":"2021-09-24","current":-125.689027,"twenty":-142.488438,"median":-68.343875,"eighty":-64.531542,"marketCap":3133553125},{"date":"2021-10-01","current":-125.259845,"twenty":-141.899846,"median":-72.31223,"eighty":-64.775748,"marketCap":3122853187},{"date":"2021-10-08","current":-128.99986,"twenty":-141.495188,"median":-120.170972,"eighty":-65.033522,"marketCap":3216095500},{"date":"2021-10-15","current":-126.424767,"twenty":-141.213154,"median":-125.137221,"eighty":-65.053873,"marketCap":3151895875},{"date":"2021-10-22","current":-131.820199,"twenty":-140.808497,"median":-125.903618,"eighty":-65.06744,"marketCap":3286409375},{"date":"2021-10-29","current":-114.652917,"twenty":-140.56325,"median":-126.118209,"eighty":-65.128491,"marketCap":2858411875},{"date":"2021-11-05","current":-129.061171,"twenty":-139.962395,"median":-125.474436,"eighty":-65.311646,"marketCap":3217624062},{"date":"2021-11-12","current":-589.248945,"twenty":-141.495188,"median":-126.424767,"eighty":-65.502641,"marketCap":3060559021},{"date":"2021-11-19","current":-544.805094,"twenty":-143.260965,"median":-127.191164,"eighty":-65.60153,"marketCap":2829717656},{"date":"2021-11-26","current":-527.145285,"twenty":-144.070281,"median":-127.405755,"eighty":-65.739007,"marketCap":2737992611},{"date":"2021-12-03","current":-499.478252,"twenty":-146.436913,"median":-127.834937,"eighty":-65.915378,"marketCap":2594290039},{"date":"2021-12-10","current":-502.127223,"twenty":-147.932919,"median":-128.63199,"eighty":-66.518929,"marketCap":2608048796},{"date":"2021-12-17","current":-500.066912,"twenty":-497.005879,"median":-128.815924,"eighty":-66.559086,"marketCap":2597347541},{"date":"2021-12-23","current":-534.503539,"twenty":-499.772582,"median":-129.061171,"eighty":-66.61408,"marketCap":2776211380},{"date":"2021-12-31","current":-560.404591,"twenty":-511.545787,"median":-130.318061,"eighty":-66.715833,"marketCap":2910741447},{"date":"2022-01-07","current":-529.794256,"twenty":-515.66641,"median":-131.820199,"eighty":-67.156761,"marketCap":2751751368},{"date":"2022-01-14","current":-520.081362,"twenty":-525.379304,"median":-135.80546,"eighty":-67.529854,"marketCap":2701302592},{"date":"2022-01-21","current":-482.112773,"twenty":-523.731055,"median":-137.522189,"eighty":-67.529854,"marketCap":2504093744},{"date":"2022-01-28","current":-481.818443,"twenty":-521.906208,"median":-139.116293,"eighty":-67.665524,"marketCap":2502564994},{"date":"2022-02-04","current":-484.467414,"twenty":-520.375692,"median":-140.77171,"eighty":-67.780844,"marketCap":2516323750},{"date":"2022-02-11","current":-503.304544,"twenty":-517.962184,"median":-141.568762,"eighty":-67.828329,"marketCap":2614163799},{"date":"2022-02-18","current":-482.995764,"twenty":-520.375692,"median":-142.794997,"eighty":-68.649134,"marketCap":2508679997},{"date":"2022-02-25","current":-471.516888,"twenty":-518.491979,"median":-143.65336,"eighty":-69.300351,"marketCap":2449058717},{"date":"2022-03-04","current":-466.513276,"twenty":-516.372802,"median":-144.082543,"eighty":-71.226868,"marketCap":2423069954},{"date":"2022-03-11","current":-464.452965,"twenty":-514.960017,"median":-144.756971,"eighty":-97.716642,"marketCap":2412368699},{"date":"2022-03-18","current":-516.5494,"twenty":-514.960017,"median":-146.780259,"eighty":-115.940463,"marketCap":2682957583},{"date":"2022-03-25","current":186.662864,"twenty":-514.960017,"median":-146.749603,"eighty":-71.226868,"marketCap":2996125630},{"date":"2022-04-01","current":192.761089,"twenty":-514.312491,"median":-144.205166,"eighty":-67.760494,"marketCap":3094008244},{"date":"2022-04-08","current":176.276824,"twenty":-513.664964,"median":-144.051887,"eighty":-66.98039,"marketCap":2829419304},{"date":"2022-04-14","current":177.229672,"twenty":-513.194036,"median":-143.65336,"eighty":-66.525531,"marketCap":2844713462},{"date":"2022-04-22","current":168.939897,"twenty":-512.54651,"median":-142.733685,"eighty":-65.502641,"marketCap":2711654284},{"date":"2022-04-29","current":165.458211,"twenty":-511.722386,"median":-141.476794,"eighty":-65.053873,"marketCap":2655769742},{"date":"2022-05-06","current":164.02856,"twenty":-511.074859,"median":-140.587775,"eighty":-64.375521,"marketCap":2632822422},{"date":"2022-05-13","current":48.465021,"twenty":-509.308879,"median":-139.085638,"eighty":-63.744655,"marketCap":2348275664},{"date":"2022-05-20","current":46.570623,"twenty":-506.659907,"median":-136.418578,"eighty":-63.235891,"marketCap":2256486388},{"date":"2022-05-27","current":46.570623,"twenty":-504.952792,"median":-134.732506,"eighty":-0.000033,"marketCap":2256486388},{"date":"2022-06-03","current":46.286463,"twenty":-504.481864,"median":-131.14577,"eighty":45.882325,"marketCap":2242717996},{"date":"2022-06-10","current":44.234198,"twenty":-503.06908,"median":-130.287406,"eighty":45.857066,"marketCap":2143279613},{"date":"2022-06-17","current":39.845509,"twenty":-502.068357,"median":-129.030516,"eighty":45.623424,"marketCap":1930634455},{"date":"2022-06-24","current":39.877082,"twenty":-501.832893,"median":-128.785269,"eighty":45.49713,"marketCap":1932164276},{"date":"2022-07-01","current":40.697988,"twenty":-501.538563,"median":-128.509366,"eighty":45.433984,"marketCap":1971939629},{"date":"2022-07-08","current":40.508549,"twenty":-500.361242,"median":-127.834937,"eighty":45.383466,"marketCap":1962760702},{"date":"2022-07-15","current":39.498203,"twenty":-499.831448,"median":-127.405755,"eighty":45.092992,"marketCap":1913806421},{"date":"2022-07-22","current":42.592387,"twenty":-499.537118,"median":-127.160508,"eighty":44.392065,"marketCap":2063728906},{"date":"2022-07-29","current":44.297345,"twenty":-499.242787,"median":-126.271488,"eighty":44.272087,"marketCap":2146339255},{"date":"2022-08-05","current":36.021023,"twenty":-498.477529,"median":-125.259845,"eighty":44.39838,"marketCap":2122322658},{"date":"2022-08-12","current":40.78048,"twenty":-498.065467,"median":-124.340169,"eighty":44.272087,"marketCap":2402745074},{"date":"2022-08-19","current":39.298026,"twenty":-497.535673,"median":-121.642453,"eighty":44.265772,"marketCap":2315400387},{"date":"2022-08-26","current":38.10166,"twenty":-497.182477,"median":-118.086373,"eighty":44.240513,"marketCap":2244911692},{"date":"2022-09-02","current":35.942999,"twenty":-496.652682,"median":-116.798827,"eighty":43.678508,"marketCap":2117725569},{"date":"2022-09-09","current":38.517787,"twenty":-496.53495,"median":-72.31223,"eighty":43.520642,"marketCap":2269429499},{"date":"2022-09-16","current":35.604896,"twenty":-496.358352,"median":-68.343875,"eighty":42.958637,"marketCap":2097804851},{"date":"2022-09-23","current":34.798649,"twenty":-496.064022,"median":-67.699442,"eighty":42.535555,"marketCap":2050301600},{"date":"2022-09-30","current":33.368211,"twenty":-495.063299,"median":-67.343308,"eighty":42.497667,"marketCap":1966021639},{"date":"2022-10-07","current":34.330506,"twenty":-493.41505,"median":-66.61408,"eighty":42.289283,"marketCap":2022719067},{"date":"2022-10-14","current":33.472243,"twenty":-492.355462,"median":-66.139234,"eighty":42.112472,"marketCap":1972151090},{"date":"2022-10-21","current":38.179684,"twenty":-490.354017,"median":-65.514401,"eighty":41.840942,"marketCap":2249508781},{"date":"2022-10-28","current":37.451461,"twenty":-487.587314,"median":-65.138666,"eighty":41.676761,"marketCap":2206602619},{"date":"2022-11-04","current":26.580134,"twenty":-485.997931,"median":-65.053873,"eighty":41.619929,"marketCap":1566074914},{"date":"2022-11-11","current":31.176487,"twenty":-485.291539,"median":-64.545109,"eighty":41.468377,"marketCap":1865694530},{"date":"2022-11-18","current":31.735024,"twenty":-484.702878,"median":-64.273769,"eighty":41.127385,"marketCap":1899119025},{"date":"2022-11-25","current":32.979037,"twenty":-484.23195,"median":-63.765005,"eighty":40.925316,"marketCap":1973564490},{"date":"2022-12-02","current":34.654646,"twenty":-483.525558,"median":-63.578459,"eighty":40.875858,"marketCap":2073837975},{"date":"2022-12-09","current":34.273826,"twenty":-482.642568,"median":-63.154489,"eighty":40.844815,"marketCap":2051048547},{"date":"2022-12-16","current":32.775933,"twenty":-482.112773,"median":-31.068498,"eighty":40.806761,"marketCap":1961410129},{"date":"2022-12-23","current":33.029813,"twenty":-481.995041,"median":26.580134,"eighty":40.747483,"marketCap":1976603081},{"date":"2022-12-30","current":33.004425,"twenty":-480.699988,"median":29.373938,"eighty":40.672729,"marketCap":1975083786},{"date":"2023-01-06","current":33.689901,"twenty":-476.22617,"median":31.227263,"eighty":40.571695,"marketCap":2016104756},{"date":"2023-01-13","current":34.070721,"twenty":-475.34318,"median":31.582696,"eighty":40.508549,"marketCap":2038894185},{"date":"2023-01-20","current":33.029813,"twenty":-473.930395,"median":31.696942,"eighty":40.497223,"marketCap":1976603081},{"date":"2023-01-27","current":34.781586,"twenty":-471.92895,"median":31.963516,"eighty":40.327941,"marketCap":2081434451},{"date":"2023-02-03","current":36.330255,"twenty":-471.04596,"median":32.026986,"eighty":40.203102,"marketCap":2174111459},{"date":"2023-02-10","current":34.172274,"twenty":-468.573586,"median":32.344336,"eighty":40.03916,"marketCap":2044971366},{"date":"2023-02-17","current":34.47693,"twenty":-466.807606,"median":32.509358,"eighty":39.902341,"marketCap":2063202908},{"date":"2023-02-24","current":34.273826,"twenty":-466.16008,"median":32.54744,"eighty":39.858138,"marketCap":2051048547},{"date":"2023-03-03","current":31.749088,"twenty":-465.748017,"median":32.522052,"eighty":39.844719,"marketCap":2051118068},{"date":"2023-03-10","current":29.804799,"twenty":-465.630285,"median":32.496664,"eighty":39.788151,"marketCap":1925509253},{"date":"2023-03-17","current":31.268734,"twenty":-465.277089,"median":32.115844,"eighty":39.693957,"marketCap":2020085302},{"date":"2023-03-24","current":31.93208,"twenty":-464.688429,"median":31.988904,"eighty":39.644105,"marketCap":2062940074},{"date":"2023-03-31","current":31.93208,"twenty":-459.684817,"median":31.988904,"eighty":39.553373,"marketCap":2062940074},{"date":"2023-04-06","current":30.056413,"twenty":-456.506051,"median":31.963516,"eighty":39.498203,"marketCap":1941764511},{"date":"2023-04-14","current":29.804799,"twenty":-454.857802,"median":31.93208,"eighty":39.472944,"marketCap":1925509253},{"date":"2023-04-20","current":29.942043,"twenty":-452.385429,"median":31.920643,"eighty":39.435056,"marketCap":1934375757},{"date":"2023-04-28","current":29.252813,"twenty":-448.323673,"median":31.840584,"eighty":39.397168,"marketCap":1889848715},{"date":"2023-05-05","current":27.979963,"twenty":-445.615836,"median":31.760412,"eighty":39.37191,"marketCap":1807617535},{"date":"2023-05-12","current":34.627744,"twenty":-147.945181,"median":31.75475,"eighty":39.340336,"marketCap":1853138367},{"date":"2023-05-19","current":36.321642,"twenty":-147.883869,"median":31.909206,"eighty":39.298026,"marketCap":1943789007},{"date":"2023-05-26","current":35.583731,"twenty":-147.785771,"median":31.93208,"eighty":39.2148,"marketCap":1904298937},{"date":"2023-06-02","current":37.387514,"twenty":-147.172654,"median":31.988904,"eighty":39.130248,"marketCap":2000830219},{"date":"2023-06-09","current":37.578825,"twenty":-146.743472,"median":32.090456,"eighty":39.068806,"marketCap":2011068386},{"date":"2023-06-16","current":38.125426,"twenty":-145.872845,"median":32.344336,"eighty":39.045238,"marketCap":2040320290},{"date":"2023-06-23","current":38.480717,"twenty":-144.867333,"median":32.496664,"eighty":39.00735,"marketCap":2059334027},{"date":"2023-06-30","current":42.033624,"twenty":-144.180641,"median":32.522052,"eighty":39.052531,"marketCap":2249471402},{"date":"2023-07-07","current":40.694451,"twenty":-144.082543,"median":32.572828,"eighty":39.298026,"marketCap":2177804237},{"date":"2023-07-14","current":42.088284,"twenty":-144.082543,"median":32.763238,"eighty":39.498203,"marketCap":2252396592},{"date":"2023-07-21","current":42.935515,"twenty":-144.033493,"median":32.801321,"eighty":39.76947,"marketCap":2297737043},{"date":"2023-07-28","current":41.596343,"twenty":-143.825033,"median":32.877485,"eighty":40.03916,"marketCap":2226069879},{"date":"2023-08-04","current":39.054648,"twenty":-143.579786,"median":32.991731,"eighty":40.327941,"marketCap":2090048526},{"date":"2023-08-11","current":45.395505,"twenty":-142.991194,"median":33.029813,"eighty":40.512933,"marketCap":2227194274},{"date":"2023-08-18","current":44.655683,"twenty":-142.75821,"median":33.080589,"eighty":40.708213,"marketCap":2190897105},{"date":"2023-08-25","current":40.54227,"twenty":-142.243191,"median":33.160148,"eighty":40.708213,"marketCap":1989084847},{"date":"2023-09-01","current":41.282092,"twenty":-141.679123,"median":33.248238,"eighty":40.78924,"marketCap":2025382016},{"date":"2023-09-08","current":39.595297,"twenty":-141.458401,"median":33.35134,"eighty":40.869406,"marketCap":1942624471},{"date":"2023-09-15","current":42.909702,"twenty":-141.127318,"median":33.472243,"eighty":40.869406,"marketCap":2105235787},{"date":"2023-09-22","current":41.311685,"twenty":-140.734923,"median":33.677207,"eighty":40.928085,"marketCap":2026833903},{"date":"2023-09-29","current":41.311685,"twenty":-140.550988,"median":33.784339,"eighty":41.003352,"marketCap":2026833903},{"date":"2023-10-06","current":41.548428,"twenty":-139.680361,"median":33.969169,"eighty":41.027593,"marketCap":2038448997},{"date":"2023-10-13","current":41.725986,"twenty":-139.079506,"median":34.045333,"eighty":41.282092,"marketCap":2047160317},{"date":"2023-10-20","current":40.54227,"twenty":-138.797473,"median":34.121498,"eighty":41.302101,"marketCap":1989084847},{"date":"2023-10-27","current":38.411581,"twenty":-138.6258,"median":34.173366,"eighty":41.295712,"marketCap":1884549001},{"date":"2023-11-03","current":39.21059,"twenty":-136.418578,"median":34.197662,"eighty":41.282092,"marketCap":1923749943},{"date":"2023-11-10","current":46.093814,"twenty":-136.418578,"median":34.273826,"eighty":41.295712,"marketCap":1964794899},{"date":"2023-11-17","current":47.322482,"twenty":-135.192343,"median":34.299214,"eighty":41.350372,"marketCap":2017168097},{"date":"2023-11-24","current":51.5781,"twenty":-134.456603,"median":34.299214,"eighty":41.400092,"marketCap":2198568106},{"date":"2023-12-01","current":52.803719,"twenty":-132.310693,"median":34.340248,"eighty":41.555151,"marketCap":2250811308},{"date":"2023-12-08","current":53.450573,"twenty":-130.741113,"median":34.434538,"eighty":41.676761,"marketCap":2278384109},{"date":"2023-12-15","current":55.22091,"twenty":-130.373242,"median":34.464236,"eighty":41.725986,"marketCap":2353846513},{"date":"2023-12-22","current":54.982595,"twenty":-130.299668,"median":34.600306,"eighty":41.884021,"marketCap":2343688113},{"date":"2023-12-29","current":56.514618,"twenty":-130.287406,"median":34.615807,"eighty":41.980485,"marketCap":2408992116},{"date":"2024-01-05","current":53.246303,"twenty":-130.287406,"median":34.654646,"eighty":42.033624,"marketCap":2269676909},{"date":"2024-01-12","current":53.654842,"twenty":-129.061171,"median":34.781586,"eighty":42.229065,"marketCap":2287091310},{"date":"2024-01-19","current":54.267651,"twenty":-129.012122,"median":34.802811,"eighty":42.424831,"marketCap":2313212911},{"date":"2024-01-26","current":56.174169,"twenty":-128.852711,"median":34.902681,"eighty":42.711712,"marketCap":2394480115},{"date":"2024-02-02","current":56.650798,"twenty":-128.766875,"median":35.073548,"eighty":43.006574,"marketCap":2414796916},{"date":"2024-02-09","current":56.650798,"twenty":-128.754613,"median":35.23857,"eighty":43.678508,"marketCap":2414796916},{"date":"2024-02-16","current":58.216866,"twenty":-128.558415,"median":35.287811,"eighty":44.369013,"marketCap":2481552119},{"date":"2024-02-23","current":58.965855,"twenty":-128.178282,"median":35.370824,"eighty":45.004587,"marketCap":2513478521},{"date":"2024-03-01","current":60.955523,"twenty":-127.883986,"median":35.433415,"eighty":45.380704,"marketCap":2273214322},{"date":"2024-03-08","current":62.551421,"twenty":-127.687789,"median":35.522046,"eighty":45.466766,"marketCap":2332730150},{"date":"2024-03-15","current":62.201102,"twenty":-127.552903,"median":35.578888,"eighty":45.920213,"marketCap":2319665700},{"date":"2024-03-22","current":62.045405,"twenty":-127.38123,"median":35.669916,"eighty":46.095098,"marketCap":2313859278},{"date":"2024-03-28","current":62.473572,"twenty":-127.258607,"median":35.85902,"eighty":46.248575,"marketCap":2329826939},{"date":"2024-04-05","current":59.94349,"twenty":-127.197295,"median":36.021023,"eighty":46.570623,"marketCap":2235472577},{"date":"2024-04-12","current":60.994447,"twenty":-126.890736,"median":36.151063,"eighty":47.312213,"marketCap":2274665928},{"date":"2024-04-19","current":57.841576,"twenty":-126.461554,"median":36.219194,"eighty":47.917463,"marketCap":2157085877},{"date":"2024-04-26","current":64.123991,"twenty":-126.302144,"median":36.287866,"eighty":49.788803,"marketCap":2391376011},{"date":"2024-05-03","current":64.591197,"twenty":-125.946536,"median":36.463158,"eighty":51.925359,"marketCap":2408799516},{"date":"2024-05-10","current":72.955782,"twenty":-125.517354,"median":36.554398,"eighty":53.028415,"marketCap":2368144672},{"date":"2024-05-17","current":73.090841,"twenty":-125.23532,"median":36.758923,"eighty":53.396101,"marketCap":2372528702},{"date":"2024-05-24","current":73.940735,"twenty":-125.174008,"median":37.048337,"eighty":53.586752,"marketCap":2400116245},{"date":"2024-05-31","current":72.062023,"twenty":-124.8184,"median":37.113785,"eighty":53.94082,"marketCap":2339133255},{"date":"2024-06-07","current":73.225035,"twenty":-123.19977,"median":37.387514,"eighty":54.14509,"marketCap":2376884630},{"date":"2024-06-14","current":74.298584,"twenty":-121.826388,"median":37.451461,"eighty":54.267651,"marketCap":2411732052},{"date":"2024-06-21","current":71.25686,"twenty":-121.67924,"median":37.503477,"eighty":55.030258,"marketCap":2312997688},{"date":"2024-06-28","current":69.646536,"twenty":-121.642453,"median":37.578825,"eighty":55.248146,"marketCap":2260726554},{"date":"2024-07-05","current":72.196216,"twenty":-121.642453,"median":37.715475,"eighty":55.391135,"marketCap":2343489183},{"date":"2024-07-12","current":70.988473,"twenty":-118.515555,"median":37.909907,"eighty":55.969899,"marketCap":2304285832},{"date":"2024-07-15","current":71.25686,"twenty":-118.343882,"median":37.967688,"eighty":56.051607,"marketCap":2312997688},{"date":"2024-08-02","current":76.177296,"twenty":-118.172209,"median":37.982658,"eighty":56.133315,"marketCap":2472715042},{"date":"2024-08-09","current":85.000861,"twenty":-117.559092,"median":38.10166,"eighty":56.501,"marketCap":2496645298},{"date":"2024-08-16","current":103.993647,"twenty":-117.166697,"median":38.175904,"eighty":56.548663,"marketCap":2551900115},{"date":"2024-08-23","current":109.8007,"twenty":-115.940463,"median":38.234746,"eighty":56.671225,"marketCap":2694399381},{"date":"2024-08-30","current":111.459858,"twenty":-97.716642,"median":38.405153,"eighty":57.701448,"marketCap":2735113457},{"date":"2024-09-06","current":112.881993,"twenty":-71.769549,"median":38.473244,"eighty":58.145711,"marketCap":2770011236},{"date":"2024-09-13","current":114.244873,"twenty":-69.449588,"median":38.517787,"eighty":58.557315,"marketCap":2803454941},{"date":"2024-09-20","current":117.385422,"twenty":-68.649134,"median":38.644697,"eighty":58.969477,"marketCap":2880520871},{"date":"2024-09-27","current":116.141054,"twenty":-67.828329,"median":38.699843,"eighty":59.94349,"marketCap":2849985314},{"date":"2024-10-04","current":117.029888,"twenty":-67.780844,"median":38.805615,"eighty":60.612989,"marketCap":2871796426},{"date":"2024-10-11","current":115.192963,"twenty":-67.665524,"median":38.863337,"eighty":60.986662,"marketCap":2826720128},{"date":"2024-10-18","current":117.6817,"twenty":-67.529854,"median":38.94479,"eighty":61.516033,"marketCap":2887791242},{"date":"2024-10-25","current":106.719407,"twenty":-67.455235,"median":38.961457,"eighty":61.726225,"marketCap":2618787526},{"date":"2024-10-31","current":110.808046,"twenty":-67.156761,"median":39.037946,"eighty":62.045405,"marketCap":2719118641},{"date":"2024-11-08","current":110.808046,"twenty":-66.715833,"median":39.071963,"eighty":62.278951,"marketCap":2719118641},{"date":"2024-11-15","current":628.179146,"twenty":-66.61408,"median":39.193994,"eighty":62.551421,"marketCap":3081846892},{"date":"2024-11-22","current":652.813623,"twenty":-66.545338,"median":39.319181,"eighty":63.18958,"marketCap":3202703633},{"date":"2024-11-29","current":676.744257,"twenty":-66.518929,"median":39.380028,"eighty":63.669251,"marketCap":3320107325},{"date":"2024-12-06","current":695.747996,"twenty":-65.915378,"median":39.435056,"eighty":64.201859,"marketCap":3413339667},{"date":"2024-12-13","current":687.30189,"twenty":-65.739007,"median":39.54675,"eighty":65.433103,"marketCap":3371903071},{"date":"2024-12-20","current":653.869386,"twenty":-65.557966,"median":39.636129,"eighty":70.478537,"marketCap":3207883208},{"date":"2024-12-27","current":665.482782,"twenty":-65.502641,"median":39.713669,"eighty":71.131613,"marketCap":3264858529},{"date":"2025-01-03","current":648.59057,"twenty":-65.372698,"median":39.844193,"eighty":71.417893,"marketCap":3181985335},{"date":"2025-01-10","current":614.454224,"twenty":-65.169192,"median":39.877082,"eighty":71.874152,"marketCap":3014512423},{"date":"2025-01-17","current":641.552148,"twenty":-65.081007,"median":40.092836,"eighty":72.196216,"marketCap":3147454838},{"date":"2025-01-24","current":648.238649,"twenty":-65.053873,"median":40.281131,"eighty":73.001379,"marketCap":3180258810},{"date":"2025-01-31","current":659.852045,"twenty":-65.053873,"median":40.494392,"eighty":73.135572,"marketCap":3237234131},{"date":"2025-02-07","current":668.298151,"twenty":-65.019955,"median":40.512677,"eighty":73.538153,"marketCap":3278670728},{"date":"2025-02-14","current":704.194102,"twenty":-64.612944,"median":40.54227,"eighty":73.717078,"marketCap":3454776264},{"date":"2025-02-21","current":659.500124,"twenty":-64.504408,"median":40.54227,"eighty":74.137552,"marketCap":3235507606},{"date":"2025-02-28","current":-25.465823,"twenty":-64.341604,"median":40.601372,"eighty":74.495402,"marketCap":2808192701},{"date":"2025-03-07","current":-21.116132,"twenty":-64.280552,"median":40.54227,"eighty":74.334369,"marketCap":2328539239},{"date":"2025-03-14","current":-19.920286,"twenty":-64.273769,"median":40.521574,"eighty":74.227014,"marketCap":2196669655},{"date":"2025-03-21","current":-21.950078,"twenty":-63.866758,"median":40.508549,"eighty":74.137552,"marketCap":2420500923},{"date":"2025-03-28","current":-22.374918,"twenty":-63.737871,"median":40.295927,"eighty":73.97652,"marketCap":2467349328},{"date":"2025-04-04","current":-23.09872,"twenty":-63.731088,"median":40.182296,"eighty":73.869165,"marketCap":2547165129},{"date":"2025-04-11","current":-21.76126,"twenty":-63.486882,"median":39.913747,"eighty":73.743917,"marketCap":2399679410},{"date":"2025-04-17","current":-21.698321,"twenty":-63.385129,"median":39.844851,"eighty":73.717078,"marketCap":2392738905},{"date":"2025-04-25","current":-22.469327,"twenty":-63.235891,"median":39.713669,"eighty":73.636562,"marketCap":2477760085},{"date":"2025-04-30","current":-22.549154,"twenty":-63.012035,"median":39.646099,"eighty":73.582885,"marketCap":2486562876}],"updateTime":1746109376766}}}